Jobs / United States / Glaxosmithkline LLC
Strategic Capability & Learning Development Lead – Drug Product Manufacturing
Glaxosmithkline LLC · 🇺🇸 USA - Pennsylvania - Marietta
Sponsorship verdict
Sponsorship possible
One solid signal, not two — worth applying, and worth asking about sponsorship early.
- Employer is on a government sponsor recordThe US Department of Labor certified 39 H-1B/E-3 labor condition applications for this employer between Oct 2025 and Jun 2026 (latest Jun 2026) — the step every H-1B hire needs first. USCIS also records 15 H-1B approvals in FY2023. Source: LCA disclosure data (US Department of Labor (OFLC)).
- The posting doesn’t mention sponsorshipSilence isn’t a refusal — ask the recruiter before investing much time.
- No salary bar for this routeH-1B has no fixed salary bar: the employer must pay at least the prevailing wage for the role and area. Cap-subject employers enter a lottery weighted by wage level. Source: https://www.federalregister.gov/documents/2025/12/29/2025-23853/weighted-selection-process-for-registrants-and-petitioners-seeking-to-file-cap-subject-h-1b, rules effective 2026-02-27.
- What Glaxosmithkline LLC paid sponsored hires in similar roles1 certified filing for “Product Owner, Planisware” (Information Technology Project Managers) in PA: $92k–$92k, median $92k. Most were filed at wage level II (100%) — 2 lottery entries, ≈31% projected selection odds for cap-subject employers. Source: US Department of Labor LCA disclosure data (Oct 2025 – Jun 2026).
- Confirmed live todayWhen a source last listed this job as open.
US H-1B: cap-subject employers enter a lottery weighted by wage level — Level I gets 1 entry, Level IV gets 4 (DHS projected selection odds ≈15% at Level I to ≈61% at Level IV). Universities and non-profit research employers are cap-exempt. The $100,000 fee for new petitions from abroad is currently blocked by a court order (appeal pending).
A verdict summarises public evidence; it is not legal advice and never a guarantee — the employer and the immigration authority decide. Sign in to factor in where you can already work.
Or apply yourself on the official page →
Sponsor Radar — Glaxosmithkline LLC
The US Department of Labor certified 39 H-1B/E-3 labor condition applications for this employer between Oct 2025 and Jun 2026 (latest Jun 2026) — the step every H-1B hire needs first. USCIS also records 15 H-1B approvals in FY2023. Source: LCA disclosure data (US Department of Labor (OFLC)).
Past sponsorship or register membership never guarantees sponsorship for this vacancy or for you. Full Sponsor Radar for Glaxosmithkline LLC →
About the role
Business Introduction: We manufacture and supply reliable, high-quality medicines and vaccines to meet patients’ needs and drive our performance. Our network of 37 medicines and vaccines manufacturing sites delivered 1.7 billion packs of medicines and 409 million vaccine doses in 2024 to help make a positive impact on the health of millions of people. Our supply chain is not just core to our operations; it’s vital to bringing our innovations to patients as quickly, efficiently and effectively as possible. Technology is transforming how we manufacture medicines and vaccines, enabling us to increase the speed and quality. We need the very best minds and capability to help us on our journey to make more complex products, harnessing the power of smart manufacturing technologies including robotics, digital solutions and artificial intelligence to deliver for patients. Position Summary: You will lead capability and development activities that strengthen our manufacturing teams and be a pivotal member of the Project team supporting the Drug Product facility at GSK’s Marietta site. This role is responsible for designing and implementing E2E capability development strategies that build critical skills, strengthen workforce, and enable a continuous learning culture aligned with the Marietta Site Strategy. You will partner with HR, site leadership, and the GPS function to align capability development, career pathways, and workforce onboarding with current and future business needs specific to Drug Product operations. Your work ensures the facility has the right talent and capabilities to drive sustained performance, resilience, and long-term success. You will work with operations, quality, engineering, and learning partners to design and deliver training, build technical capability, and improve how people learn on the job. We value clear communicators, practical problem solvers, and hands-on coaches who enjoy helping others grow. This role offers career growth, visible impact on manufacturing performance, and a chance to contribute to GSK’s mission of uniting science, technology and talent to get ahead of disease together. Key Responsibilities • Own the Drug Product facility capability strategy and 3-year capability roadmap, aligning priorities and milestones with site strategy. • Bring and lead deployment of digital tools, augmented reality, AI, and other smart learning technologies to accelerate learning and development content creation, improve learner engagement, and scale capability-building across Drug Product operations. • Plan, manage, and track development of training materials for the new Drug Product Manufacturing facility using tools such as Microsoft Project, and develop and maintain dashboards to communicate progress, escalations, risks, and status to leadership. • Collaborate with Operations Managers, Engineering, MSAT, and other cross-functional partners to drive creation, review, and deployment of learning and development content aligned with Drug Product manufacturing readiness needs. Design and maintain the Drug Product facility capability operating system, linking strategy to capability requirements, pathways, assessment, deployment, and sustainment within a manufacturing environment. • Establish standard ownership and sustainment expectations for embedding capability into daily work at the Drug Product facility. • Lead the Learning Council to prioritize capability work, maintain alignment, and manage roadmaps for Drug Product operations. • Drive adoption and sustainment of major capability deployments using disciplined change enablement. Build and maintain role-based learning pathways and competency expectations for priority and future roles within drug product manufacturing. • Leverage learning technologies